Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,077 public trials 1,842 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Active, Not Recruiting

POTENT - Tepotinib in Combination With Pembrolizumab in NSCLC

NCT05782361

Conditions
Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • DDU, Royal Marsden Hospital NHS Foundation Trust Sutton, Surrey, United Kingdom
  • University College London Hospitals NHS Foundation Trust London, United Kingdom
  • Lung Unit, Royal Marsden Hospital NHS Foundation Trust London, United Kingdom
  • The Christie NHS Foundation Trust Manchester, United Kingdom
View Trial Details
Active, Not Recruiting

A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation

NCT04280081

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +25 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • The First Affiated Hospital Of Guangzhou Medical University Guangzhou, Guangdong, China
  • Southern Medical University Nanfang Hospital Guangzhou, Guangdong, China
  • Hunan Cancer Hospital Changsha, Hunan, China
View all 13 locations
View Trial Details
Active, Not Recruiting

Whole Genomic Landscape of Advanced EGFR-mutant NSCLC

NCT03969823

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Seoul National University Bundang Hospital Seongnam, South Korea
  • Borame Medical Center Seoul, South Korea
  • Seoul National University Hospital Seoul, South Korea
View Trial Details
Active, Not Recruiting

Osimertinib Plus Savolitinib in EGFRm+/MET+ NSCLC Following Prior Osimertinib

NCT03778229

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +10 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Sacramento, California, United States
  • Research Site Washington D.C., District of Columbia, United States
View all 90 locations
View Trial Details
Active, Not Recruiting

Durvalumab Maintenance After Thoracic Chemoradiotherapy in Frail Small Cell Lung Cancer Patients Whose Disease is Limited to the Thorax

NCT05617963

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
Locations
  • Centre de Radiothérapie du Pays d'Aix Aix-en-Provence, France
  • Centre Hospitalier du Pays d'Aix Aix-en-Provence, France
  • Institut du Cancer Avignon-Provence Avignon, France
  • Centre d'Oncologie du Pays Basque Bayonne, France
View all 32 locations
View Trial Details
Active, Not Recruiting

Phase III, Open-label, First-line Study of Dato-DXd in Combination With Durvalumab and Carboplatin for Advanced NSCLC Without Actionable Genomic Alterations

NCT05687266

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Tucson, Arizona, United States
  • Research Site Hot Springs, Arkansas, United States
  • Research Site Little Rock, Arkansas, United States
View all 254 locations
View Trial Details

Related conditions